Blog
Follow us for the latest trends, insights and innovations in the pharmaceutical industry.
The Hidden Cost of Switching Pharmaceutical Intermediate Suppliers: A Buyer’s Calculator
Switching intermediate suppliers for 20% lower price? Six hidden costs including bridging studies, regulatory filings, and method revalidation can reach $600K.
Read More →
ICH Q2 Analytical Method Validation: What Your Intermediate COA Doesn’t Tell You
This guide decodes the seven validation parameters defined in ICH Q2(R2) from an intermediate buyer's perspective, explains why stability-indicating methods matter for retest dating, and ...
Read More →
ICH Q11 Starting Material Selection: A Practical Guide for Pharmaceutical Intermediate Buyers
Learn how ICH Q11 starting material rules affect pharmaceutical intermediate sourcing—supplier boundaries, COA red flags, and a practical buyer's checklist.
Read More →
Polymorphism in Pharmaceutical Intermediates: Why Solid Form Control Matters
This guide explains what polymorphism means for intermediate buyers, how ICH Q6A Decision Tree #4 governs solid form control, which COA red flags signal polymorph ...
Read More →




